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We note with great enthusiasm the recent cabinet decision on
the roll-out of antiretrovirals (ARVs) in South Africa.1
According to information from the Treatment Action Campaign
(TAC) on the cabinet document, ‘Treatment Options to
Supplement Comprehensive Care for HIV/AIDS in the Public
Health Sector’ presented to MINMEC on 9 May 2003,2,3 we
note, among other items, that the document may
underestimate the role of ARVs in preventing HIV infection.
We would like to present a case in favour of ARVs as a strategy
in the fight against this epidemic.
With reference to the section headed ‘Benefits of ARV
treatment’, there appears to be an underestimate of the role of
antiretrovirals in preventing new infections. The section states
that there is ‘… no compelling evidence that ARVs would
reduce numbers of new infections …’. Prevention of new
infections may in fact be decreased in a number of ways: (i) by
decreasing the viral load in the mother, transmission to the
infant is significantly decreased;4 (ii) decreasing the viral load
in patients reduces horizontal transmission, 5 and may well
have a beneficial epidemic-level effect; (iii) modelling exercises
based on examples from developed and developing countries
have shown that antiretrovirals, even in the light of resistance,
significantly decrease the transmission of HIV-1 in high,
intermediate and low ARV usage scenarios.6 On the basis of
this model and other adapted models,7 taking into account the
effect of resistance developing on ARVs,8 it is estimated that 10
- 30% of new infections in South Africa could be averted if 50%
of patients who require antiretrovirals were receiving them; (iv)
improved AIDS care may indirectly enhance prevention efforts
through increased uptake of voluntarily testing and
counselling, the foundation and entry point to all care
interventions;9 (v) improved care leads to de-stigmatisation of
the disease,10,11 which improves compliance and access to health
care.9
South African prices for both first-line regimens are
significantly more expensive than the best world prices. The
costs could be dramatically reduced by facilitating domestic
production or importation of generics, reflected in the
imminent production of generic ARVs by South African drug
companies,12 and affords the opportunity to double or treble
the number of patients that could benefit from ARVs.
While we agree that it is imperative that any programme
should ultimately reach those in ‘desperate need’ this should
not delay implementation in regions with the necessary
infrastructure in place. It should not be assumed that this will
only be in urban areas. Several institutions in rural KwaZulu-
Natal could implement ARVs immediately. The constitution
guarantees all South Africans the right to access health care,
and we understand the government’s concerns regarding
initially providing ARVs to specific groups such as teachers or
health staff. However, this would have two advantages. It
would help maintain essential public services. It would also
enable managers to evaluate and rectify possible problems in a
sub-group of the population that is better educated and better
nourished before rolling out to the rest of the country, and this
sub-group of patients could act as advocates for compliance
issues associated with long-term HAART therapy. As many
privately employed South Africans already have access to
ARVs a disparity in health care already exists.
Following this announcement, we urge the government to
implement a widespread public ARV programme without
further delay, starting in areas of adequate resource. A novel
approach to reach areas of most need could be to encourage
provinces with expertise, such as KwaZulu-Natal, Gauteng,
Western Cape and Free State, to ‘adopt’ neighbouring
provinces to assist with setting up pilot sites and rapidly
scaling up, thus sharing expertise and resources such as
training and technical support.
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A tobacco-free hospital environment sends an important signal
to patients and visitors with regard to both safety and a
healthy lifestyle. Today patients, staff and visitors increasingly
expect an antismoking policy to be in place in hospitals and
other venues where sick people are treated. Health care staff
can play an important role in the implementation of an
antismoking policy in their hospital.
Eighty per cent of the medical, technical and nursing staff of
the Magenta Hospital in Italy1 were in favour of a total ban on
smoking inside the hospital. It was interesting to note that
these workers underestimated the health risks of smoking:
only 34% of doctors, 13% of nurses and 16% of technicians
identified smoking as the main preventable cause of death in
Italy at the time of the survey.
A smoking control programme involving all staff members
was instituted in a hospital in Barcelona, Spain.2 Within 18
months the prevalence of smoking decreased from 51% to 40%
and the percentage of ex-smokers increased from16% to 23%.
There was also a noticeable change in the attitude of the health
workers, especially with regard to encouraging patients to stop
smoking.
The aim of the present study was to examine the smoking
habits of a sample of the nursing staff in clinical wards in
Tygerberg Hospital, and to ascertain their opinions on the
introduction of an antismoking policy.
What was done
This study constituted part of the training of fourth-year
medical students and was carried out under the supervision of
the Department of Community Health of the University of
Stellenbosch. Permission to interview nursing staff was granted
by the authorities of Tygerberg Hospital. Participation was
voluntary and informed consent was obtained from all
participants. Care was taken that participation in the survey
did not impact on the participants’ work schedule.
Five clinical locations representing a cross-section of clinical
activities at the hospital were selected for inclusion in the
study. The locations selected were obstetrics and gynaecology,
trauma, psychiatry, respiratory intensive care, and the burns
unit. An anonymous, self-completed questionnaire was
compiled for the survey and tested on a few non-sampled
respondents for comprehensibility and length. The final
questionnaire was simplified a little. The questions dealt with
smoking behaviour, the advisability of smoking in a hospital,
and feelings about an antismoking policy.
The questionnaires were handed individually to the nurses
in the selected wards and they were requested not to discuss
the contents with their colleagues. A sealed ‘post’ box with a
slot cut in the lid was made so that respondents could place
their completed answers in the box anonymously. This was
661
STUDENT PAPER
Smoking among nursing staff at Tygerberg Hospital, 
Cape Town
F W Retief, E Prinsloo, J Calitz, J M Barnes
September 2003, Vol. 93, No. 9  SAMJ
The first three authors were fourth-year medical students at the
University of Stellenbosch when they did this research project,
which was supervised by Jo Barnes, of the Department of
Community Health.
in developing countries. AIDScience 2003; 3(11)
http://www.aidscience.com/Articles/aidscience033.asp (last accessed 15 Aug 2003).
7. Wood E, Braitstein P, Montaner JSG, et al. Extent to which low-level use of antiretroviral
treatment could curb the AIDS epidemic in sub-Saharan Africa. Lancet 2000; 355:
http://pdf.thelancet.com/pdfdownload?uid=llan.355.9221.original_research.1248.1&x=x.pdf
(last accessed 15 Aug 2003). 
8. Little SJ, Holte S, Routy JP, et al. Antiretroviral-drug resistance among patients recently
infected with HIV. N Engl J Med 2002; 347: 385-394.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=121
67680&dopt=Abstract (last accessed 15 Aug 2003).
9. Levi GC, Vitoria MA. Fighting against AIDS: The Brazilian Experience. AIDS 2002; 16: 2373-
2383.
10. Farmer P, Léandre F, Mukherjee JS, et al. Community-based approaches to HIV treatment in
resource-poor settings. Lancet 358; 
11. Farmer P, Leandre F, Mukherjee J, Gupta R, Tarter L, Kim JY. Community-based treatment of
advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly
active antiretroviral therapy). Bull World Health Organ 2001; 79(12): 1145-1151.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=
11799447&dopt=Abstract (last accessed 15 Aug 2003).
12. SAPA. Local firm launches new, cheaper Aids drug. 2003.
http://www.iol.co.za/index.php?set_ id=1&click_id=13&art_id=qw1060182181723B232 (last
accessed 15 Aug 2003).
